Neurologic Clinics: Vol 42 – N1 (Multiple Sclerosis)

مولف

CARRIE M. HERSH

ناشر

‎ Elsevier

تخصص

Neurology

ویراست

Volume 42 . Number 1

سال انتشار

2024

قطع

رحلی A4 استاندارد

تعداد صفحات

356

ISBN

978-0-323-93917-1

Neurologic Clinics: Vol 42 – N1 (Multiple Sclerosis) 2024

* Multiple Sclerosis Diagnostic Delay and Misdiagnosis
Marwa Kaisey and Andrew J. Solomon

* Recent Advances in Diagnostic, Prognostic, and Disease-Monitoring Biomarkers in Multiple Sclerosis
Anibal Chertcoff, Raphael Schneider, Christina J. Azevedo, Nancy Sicotte, and Jiwon Oh

* Pathophysiology, Diagnosis, Treatment and Emerging Neurotherapeutic Targets for Progressive Multiple Sclerosis: The Age of PIRA
Alise K. Carlson and Robert J. Fox

* Relationship Between Multiple Sclerosis, Gut Dysbiosis, and Inflammation: Considerations for Treatment
Larissa Jank and Pavan Bhargava

* Updates in NMOSD and MOGAD Diagnosis and Treatment: A Tale of Two Central Nervous System Autoimmune Inflammatory Disorders 
Laura Cacciaguerra and Eoin P. Flanagan

* Advances in Multiple Sclerosis Neurotherapeutics, Neuroprotection, and Risk Mitigation Strategies
Ahmad Abdelrahman and Enrique Alvarez

* Role of B Cells in Relapsing-Remitting and Progressive Multiple Sclerosis and Long-Term Effects of B Cell Depletion
Afsaneh Shirani, Olaf Stuve, and Anne H. Cross

* Bruton’s Tyrosine Kinase Inhibitors for Multiple Sclerosis Treatment: A New Frontier
Benjamin M. Greenberg

* Autologous Hematopoietic Stem Cell Transplantation to Treat Multiple Sclerosis
Lindsay A. Ross, Lisa M. Stropp, and Jeffrey A. Cohen

* What Is the Future of Multiple Sclerosis Treatment?
Nicole Bou Rjeily, Ellen M. Mowry, Daniel Ontaneda, and Alise K. Carlson

* Leveraging Real-World Evidence and Observational Studies in Treating Multiple Sclerosis
Albert Aboseif, Izanne Roos, Stephen Krieger, Tomas Kalincik, and Carrie M. Hersh

* Health, Wellness, and the Effect of Comorbidities on the Multiple Sclerosis Disease Course: Tackling the Modifiable
Devon S. Conway, Amy B. Sullivan, and Mary Rensel

* Clinical and Treatment Considerations for the Pediatric and Aging Patients with Multiple Sclerosis
Areeba Siddiqui, Jennifer H. Yang, Le H. Hua, and Jennifer S. Graves

* Women’s Health and Pregnancy in Multiple Sclerosis
Riley Bove, Paige Sutton, and Jacqueline Nicholas

* Multiple Sclerosis in Black and Hispanic Populations: Serving the Underserved
Mitzi J. Williams, Christopher Orlando, Jemima Akisanya, and Lilyana Amezcua

* Era of COVID-19 in Multiple Sclerosis Care
Jonathan D. Krett, Amber Salter, and Scott D. Newsome

جهت مشاهده قیمت و خرید محصول پس از انتخاب نوع صحافی دلخواه و تعداد مورد نظر ، محصول را به سبد خرید اضافه کنید
پاک کردن

Total

▼ محصولات مرتبط ▼

▼ نمونه صفحات ▼

Neurologic Clinics: Vol 42 – N1 (Multiple Sclerosis) 2024

* Multiple Sclerosis Diagnostic Delay and Misdiagnosis
Marwa Kaisey and Andrew J. Solomon

* Recent Advances in Diagnostic, Prognostic, and Disease-Monitoring Biomarkers in Multiple Sclerosis
Anibal Chertcoff, Raphael Schneider, Christina J. Azevedo, Nancy Sicotte, and Jiwon Oh

* Pathophysiology, Diagnosis, Treatment and Emerging Neurotherapeutic Targets for Progressive Multiple Sclerosis: The Age of PIRA
Alise K. Carlson and Robert J. Fox

* Relationship Between Multiple Sclerosis, Gut Dysbiosis, and Inflammation: Considerations for Treatment
Larissa Jank and Pavan Bhargava

* Updates in NMOSD and MOGAD Diagnosis and Treatment: A Tale of Two Central Nervous System Autoimmune Inflammatory Disorders 
Laura Cacciaguerra and Eoin P. Flanagan

* Advances in Multiple Sclerosis Neurotherapeutics, Neuroprotection, and Risk Mitigation Strategies
Ahmad Abdelrahman and Enrique Alvarez

* Role of B Cells in Relapsing-Remitting and Progressive Multiple Sclerosis and Long-Term Effects of B Cell Depletion
Afsaneh Shirani, Olaf Stuve, and Anne H. Cross

* Bruton’s Tyrosine Kinase Inhibitors for Multiple Sclerosis Treatment: A New Frontier
Benjamin M. Greenberg

* Autologous Hematopoietic Stem Cell Transplantation to Treat Multiple Sclerosis
Lindsay A. Ross, Lisa M. Stropp, and Jeffrey A. Cohen

* What Is the Future of Multiple Sclerosis Treatment?
Nicole Bou Rjeily, Ellen M. Mowry, Daniel Ontaneda, and Alise K. Carlson

* Leveraging Real-World Evidence and Observational Studies in Treating Multiple Sclerosis
Albert Aboseif, Izanne Roos, Stephen Krieger, Tomas Kalincik, and Carrie M. Hersh

* Health, Wellness, and the Effect of Comorbidities on the Multiple Sclerosis Disease Course: Tackling the Modifiable
Devon S. Conway, Amy B. Sullivan, and Mary Rensel

* Clinical and Treatment Considerations for the Pediatric and Aging Patients with Multiple Sclerosis
Areeba Siddiqui, Jennifer H. Yang, Le H. Hua, and Jennifer S. Graves

* Women’s Health and Pregnancy in Multiple Sclerosis
Riley Bove, Paige Sutton, and Jacqueline Nicholas

* Multiple Sclerosis in Black and Hispanic Populations: Serving the Underserved
Mitzi J. Williams, Christopher Orlando, Jemima Akisanya, and Lilyana Amezcua

* Era of COVID-19 in Multiple Sclerosis Care
Jonathan D. Krett, Amber Salter, and Scott D. Newsome